These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 14685049)

  • 1. Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials.
    Peeters M; Toure-Kane C; Nkengasong JN
    AIDS; 2003 Dec; 17(18):2547-60. PubMed ID: 14685049
    [No Abstract]   [Full Text] [Related]  

  • 2. [How many HIV's are there?].
    Holguín A; Soriano V
    Med Clin (Barc); 1998 May; 110(17):657-61. PubMed ID: 9656210
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV global surveillance: foundation for retroviral discovery and assay development.
    Brennan CA; Bodelle P; Coffey R; Harris B; Holzmayer V; Luk KC; Swanson P; Yamaguchi J; Vallari A; Devare SG; Schochetman G; Hackett J
    J Med Virol; 2006; 78 Suppl 1():S24-9. PubMed ID: 16622874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of genetic diversity of HIV-1 on diagnosis, antiretroviral therapy & vaccine development.
    Lal RB; Chakrabarti S; Yang C
    Indian J Med Res; 2005 Apr; 121(4):287-314. PubMed ID: 15817945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity, drug resistance, and the epidemic of subtype C HIV-1 in Africa.
    Katzenstein D
    J Infect Dis; 2006 Sep; 194 Suppl 1():S45-50. PubMed ID: 16921472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali.
    Derache A; Traore O; Koita V; Sylla A; Tubiana R; Simon A; Canestri A; Carcelain G; Katlama C; Calvez V; Cisse M; Marcelin AG
    Antivir Ther; 2007; 12(1):123-9. PubMed ID: 17503757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrase polymorphism and HIV-1 group O diversity.
    Leoz M; Depatureaux A; Vessière A; Roquebert B; Damond F; Rousset D; Roques P; Simon F; Plantier JC;
    AIDS; 2008 Jun; 22(10):1239-43. PubMed ID: 18525277
    [No Abstract]   [Full Text] [Related]  

  • 8. HIV diversity, recombination and disease progression: how does fitness "fit" into the puzzle?
    Tebit DM; Nankya I; Arts EJ; Gao Y
    AIDS Rev; 2007; 9(2):75-87. PubMed ID: 17694675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The origin and diversity of the HIV-1 pandemic.
    Hemelaar J
    Trends Mol Med; 2012 Mar; 18(3):182-92. PubMed ID: 22240486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the genetic diversity of HIV-1.
    McCutchan FE
    AIDS; 2000; 14 Suppl 3():S31-44. PubMed ID: 11086847
    [No Abstract]   [Full Text] [Related]  

  • 11. [HIV genetic diversity and its consequences].
    Roquebert B; Damond F; Brun-Vézinet F; Descamps D
    Pathol Biol (Paris); 2009 Mar; 57(2):142-8. PubMed ID: 18511216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of HIV strains impacts diagnostic test accuracy.
    AIDS Patient Care STDS; 2009 Mar; 23(3):220. PubMed ID: 19866540
    [No Abstract]   [Full Text] [Related]  

  • 13. Virology of HIV-1 and HIV-2: implications for Africa.
    Kanki PJ; Peeters M; Guéye-Ndiaye A
    AIDS; 1997; 11 Suppl B():S33-42. PubMed ID: 9416365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of HIV in Ghana: dominance of CRF02_AG.
    Fischetti L; Opare-Sem O; Candotti D; Sarkodie F; Lee H; Allain JP
    J Med Virol; 2004 Jun; 73(2):158-66. PubMed ID: 15122787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients.
    Charpentier C; Nora T; Tenaillon O; Clavel F; Hance AJ
    J Virol; 2006 Mar; 80(5):2472-82. PubMed ID: 16474154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance of the genetic variation in incident HIV, HCV, and HBV infections in blood and plasma donors: implications for blood safety, diagnostics, treatment, and molecular epidemiology.
    Delwart E; Kuhns MC; Busch MP
    J Med Virol; 2006; 78 Suppl 1():S30-5. PubMed ID: 16622875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will ART rollout in Africa drive an epidemic of drug resistant HIV?
    Hastings IM; Lalloo D; Khoo SH
    AIDS; 2006 Jun; 20(9):1354-6; author reply 1356-7. PubMed ID: 16816578
    [No Abstract]   [Full Text] [Related]  

  • 18. Global epidemiology of HIV.
    McCutchan FE
    J Med Virol; 2006; 78 Suppl 1():S7-S12. PubMed ID: 16622870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first B/G intersubtype recombinant form of human immunodeficiency virus type 1 (HIV-1) identified in Germany was undetected or underquantitated by some commercial viral load assays.
    von Truchsess I; Harris B; Schätzl HM; Hackett J
    J Med Virol; 2006 Mar; 78(3):311-7. PubMed ID: 16419111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HIV-1 Non-subtype B Workgroup: an international collaboration for the collection and analysis of HIV-1 non-subtype B data.
    Kantor R; Shafer RW; Katzenstein D;
    MedGenMed; 2005 Feb; 7(1):71. PubMed ID: 16369376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.